Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Journal of Cellular and Molecular Medicine|July 3, 2019
CRISPR/dCas9-mediated activation of multiple endogenous target genes directly converts human foreskin fibroblasts into Leydig-like cellsHua Huang, Xiangyu Zou, Liang Zhong, et al.
Stem Cell Research & Therapy|July 3, 2020
Extracellular vesicles from adipose-derived stem cells ameliorate ultraviolet B-induced skin photoaging by attenuating reactive oxygen species production and inflammationPeng Xu, Yu Xin, Zheng Zhang, et al.
Biomolecules|September 28, 2024
A New Rat Model of Sacral Cord Injury Producing a Neurogenic Bladder and Its Functional and Mechanistic StudiesKaiping Bai, Yanping Hou, Zhiyuan Zhang, et al.
Peerj|May 17, 2023
A new application of multiplex PCR combined with membrane biochip assay for rapid detection of 9 common pathogens in sepsisYun Li, LuJie Zhao, Jingye Wang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 17, 2017
Magnolin inhibits prostate cancer cell growth in vitro and in vivoYeqing Huang, Xiangyu Zou, Xiaowen Zhang, et al.
Stem Cells Translational Medicine|February 16, 2018
Targeting Murine Mesenchymal Stem Cells to Kidney Injury Molecule-1 Improves Their Therapeutic Efficacy in Chronic Ischemic Kidney InjuryXiangyu Zou, Kai Jiang, Amrutesh S Puranik, et al.
International Journal of General Medicine|June 30, 2021
Polycyclic Aromatic Hydrocarbons and the Risk of Kidney Stones in US Adults: An Exposure-Response Analysis of NHANES 2007-2012Si Sun, Weipu Mao, Shuchun Tao, et al.
Diabetes, Obesity & Metabolism|October 23, 2025
Renal lipotoxicity in diabetic and obesity-associated kidney diseases: Molecular mechanisms and therapeutic targetingQing Liu, Shangze Guo, Yinghao Tong, et al.
Biomaterials Advances|October 19, 2023
A dual drug-loaded peptide system with morphological transformation prolongs drug retention and inhibits breast cancer growthXiaoqing Zhai, Shusen Tang, Fanhu Meng, et al.
Environmental Toxicology|November 27, 2023
Cisplatin induces acute kidney injury by downregulating miR-30e-5p that targets Galnt3 to activate the AMPK signaling pathwayWeipu Mao, Lei Zhang, Yiduo Wang, et al.
Pageof 6